Iron deficiency (ID) is common in patients with cardiovascular disease. Up to 60% of patients
with coronary artery disease, and an even higher proportion of those with heart failure (HF) …

Iron deficiency and iron overload are the most prevalent and opposite forms of dysregulated
iron metabolism that affect approximately 30 percent of the world population, in particularly …

Non-anaemic iron deficiency (NAID) is a strategic target in cardiovascular medicine because
of its association with a range of adverse effects in various conditions. Endeavours to tackle …

Systemic iron deficiency (SID), even in the absence of anaemia, worsens the prognosis and
increases mortality in heart failure (HF). Recent clinical–epidemiological studies, however …

Background: The association of chronic heart failure (CHF) and iron deficiency (ID) with or
without anemia is frequently encountered in current medical practice and has a negative …

In patients with a first anterior ST-segment elevation myocardial infarction treated with
primary percutaneous coronary intervention, iron deficiency (ID) was associated with larger …

Aims Heart failure (HF) after myocardial infarction (MI) is a major cause of morbidity and
mortality. We sought to investigate the functional importance of cardiac iron status after MI …

Background Iron deficiency (ID) is an important predictor of adverse outcomes in patients
with heart failure, however it is unclear whether ID also affects prognosis in patients with …

Introduction The role of erythrocytes in the acute coronary syndrome (ACS) is complex. The
aim of this review in terms of PICO (P: patients; I: intervention; C: comparison; O: outcome) …

Iron deficiency has been extensively researched and is associated with adverse outcomes
in heart failure. However, to our knowledge, the temporal evolution of iron status has not …